Stock data
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU) reported revenue of US$11.16M and net income of -US$148.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$11.16M | — | -US$148.34M | -US$148.12M | — |
| 2024 | US$9.99M | — | -US$166.62M | -US$149.10M | — |
| 2023 | US$34.48M | — | -US$116.06M | -US$102.07M | — |
| 2022 | US$13.85M | — | -US$106.40M | -US$99.42M | — |
| 2021 | US$9.60M | — | -US$66.98M | -US$66.92M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.50M | -US$24.28M | — |
| 2026-03-31 | US$2.40M | -US$25.09M | — |
| 2025-12-31 | US$3.94M | -US$26.49M | — |
| 2025-09-30 | US$2.20M | -US$27.55M | — |
| 2025-06-30 | US$2.67M | -US$54.10M | — |
| 2025-03-31 | US$2.35M | -US$39.99M | — |
| 2024-12-31 | US$2.08M | -US$35.49M | — |
| 2024-09-30 | US$2.02M | -US$34.68M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.